• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“铁路征”:胎盘植入谱系疾病中一种提示绒毛膜侵袭较深和不良结局的超声表现。

The "rail sign": an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes.

机构信息

Departments of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

Departments of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Am J Obstet Gynecol. 2021 Sep;225(3):292.e1-292.e17. doi: 10.1016/j.ajog.2021.03.018. Epub 2021 Mar 17.

DOI:10.1016/j.ajog.2021.03.018
PMID:33744177
Abstract

BACKGROUND

Ultrasound has demonstrated a high accuracy in the prenatal diagnosis of placenta accreta spectrum. However, it is not known whether ultrasound findings can pinpoint the depths of villous invasion, recommend surgical strategies, and predict clinical outcomes.

OBJECTIVE

We described an ultrasound descriptor for the placenta accreta spectrum and investigated whether it can predict the severity of villous invasion and clinical outcomes.

STUDY DESIGN

The patients with placenta accreta spectrum in this retrospective cross-sectional study were diagnosed and managed in our hospital from 2002 to 2017. The placenta, with overlying myometrium and bladder, was mapped with color Doppler sonography while the patient's bladder was full. A "rail sign" was defined as 2 parallel neovascularizations depicted by color Doppler sonography over the uterovesical junction and bladder mucosa, with interconnecting bridging vessels perpendicular to both. The patients received serial ultrasound examinations and surgery at our hospital. An unpaired t test and Pearson chi-square test compared the pathology subtypes, surgical strategies, and clinical outcomes in patients with or without a rail sign.

RESULTS

We enrolled 133 consecutive cases of placenta accreta spectrum confirmed either by surgical inspection or pathology examination. Patients with a rail sign had a significantly higher risk of an abnormally invasive placenta (placenta increta or placenta percreta) than those patients without a rail sign (83.3% [60 of 72] vs 27.9% [17 of 61]; odds ratio, 12.94; P<.001). In addition, patients with a rail sign had a higher probability of perioperative approaches, including preoperative vascular control (58.3% [42 of 72] vs 21.3% [13 of 61]; odds ratio, 5.17; P<.001) and uterine artery embolization (34.7% [25 of 72] vs 11.5% [7 of 61]; odds ratio, 4.1; P=.0002]. Furthermore, patients with a rail sign carried a higher risk of adverse clinical outcomes than patients without a rail sign, such as blood transfusion (80.6% [58 of 72] vs 36.1% [22 of 61]; odds ratio, 7.34; P<.001], admission to the intensive care unit (33.3% [24 of 72] vs 16.4% [10 of 61]; odds ratio, 2.55; P=.026), hysterectomy (75% [54 of 72] vs 24.6% [15 of 61]; odds ratio, 9.2; P<.001), and bladder invasion (16.7% [12 of 72] vs 4.9% [3 of 61]; odds ratio, 3.86; P=.033). Notably, the negative predictive value of bladder invasion was 95.1%, indicating a high confidence to reject bladder invasion while the rail sign was negative. When the rail sign was used as a screening test, the positive likelihood ratio of predicting deep villous invasion was 3.64 and correlated with an increased probability of 20% to 25%. Patients with a rail sign also had a greater blood loss (2944±2748 mL vs 1530±1895 mL; P<.001) and a longer hospital stay (11.9±10.9 days vs 8.6±7.1 days; P=.036) than patients without a rail sign.

CONCLUSION

A "rail sign" depicted by color Doppler sonography correlates with deeper villous invasion, additional perioperative approaches, and more adverse outcomes.

摘要

背景

超声在胎盘植入谱系疾病的产前诊断中具有较高的准确性。然而,目前尚不清楚超声检查结果是否可以确定绒毛侵入的深度、推荐手术策略并预测临床结局。

目的

我们描述了胎盘植入谱系疾病的一种超声描述符,并探讨了其是否可以预测绒毛侵犯的严重程度和临床结局。

研究设计

本回顾性横断面研究纳入了 2002 年至 2017 年在我院诊断和治疗的胎盘植入谱系疾病患者。患者膀胱充盈时,使用彩色多普勒超声对胎盘(包括附着于其上的子宫肌层和膀胱)进行映射。“轨道征”定义为在膀胱黏膜上和子宫膀胱交界处,由彩色多普勒超声显示的 2 条平行的新生血管,其间有垂直于两者的连接桥血管。患者在我院接受了连续的超声检查和手术。采用独立样本 t 检验和 Pearson 卡方检验比较了有和无轨道征患者的病理亚型、手术策略和临床结局。

结果

我们共纳入了 133 例经手术检查或病理检查证实的胎盘植入谱系疾病连续病例。有轨道征的患者异常性胎盘植入(胎盘植入或胎盘穿透)的风险明显高于无轨道征的患者(83.3%[60/72]比 27.9%[17/61];比值比,12.94;P<.001)。此外,有轨道征的患者更有可能采用围手术期方法,包括术前血管控制(58.3%[42/72]比 21.3%[13/61];比值比,5.17;P<.001)和子宫动脉栓塞术(34.7%[25/72]比 11.5%[7/61];比值比,4.1;P=.0002)。此外,有轨道征的患者与无轨道征的患者相比,有更高的发生不良临床结局的风险,如输血(80.6%[58/72]比 36.1%[22/61];比值比,7.34;P<.001)、入住重症监护病房(33.3%[24/72]比 16.4%[10/61];比值比,2.55;P=.026)、子宫切除术(75%[54/72]比 24.6%[15/61];比值比,9.2;P<.001)和膀胱侵犯(16.7%[12/72]比 4.9%[3/61];比值比,3.86;P=.033)。值得注意的是,膀胱侵犯的阴性预测值为 95.1%,这表明当轨道征为阴性时,对膀胱侵犯有很高的置信度可以排除。当轨道征作为筛选试验时,预测深层绒毛侵犯的阳性似然比为 3.64,与增加 20%至 25%的可能性相关。有轨道征的患者还具有更大的出血量(2944±2748 mL 比 1530±1895 mL;P<.001)和更长的住院时间(11.9±10.9 天比 8.6±7.1 天;P=.036)。

结论

彩色多普勒超声显示的“轨道征”与更深的绒毛侵犯、更多的围手术期方法和更差的临床结局相关。

相似文献

1
The "rail sign": an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes.“铁路征”:胎盘植入谱系疾病中一种提示绒毛膜侵袭较深和不良结局的超声表现。
Am J Obstet Gynecol. 2021 Sep;225(3):292.e1-292.e17. doi: 10.1016/j.ajog.2021.03.018. Epub 2021 Mar 17.
2
Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness.胎盘植入:产前超声成像及绒毛侵入程度分级的系统评价
Am J Obstet Gynecol. 2016 Dec;215(6):712-721. doi: 10.1016/j.ajog.2016.07.044. Epub 2016 Jul 26.
3
The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.经阴道超声在胎盘植入谱系疾病高危产妇分娩前评估中的作用。
Am J Obstet Gynecol. 2023 Oct;229(4):445.e1-445.e11. doi: 10.1016/j.ajog.2023.05.004. Epub 2023 May 13.
4
Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean delivery.在前置胎盘且有剖宫产史的妇女中,利用超声进行侵袭性胎盘的产前诊断。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:97-103. doi: 10.1016/j.ejogrb.2024.08.035. Epub 2024 Aug 28.
5
The role of ultrasound in prediction of intra-operative blood loss in cases of placenta accreta spectrum disorders.超声在预测胎盘植入谱系疾病术中出血量中的作用。
Arch Gynecol Obstet. 2020 Nov;302(5):1143-1150. doi: 10.1007/s00404-020-05707-y. Epub 2020 Aug 1.
6
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.前瞻性评估剖宫产术后子宫瘢痕对胎盘植入谱系疾病围产期诊断的影响。
Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8.
7
Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.胎盘植入谱系疾病的趋势、特征和结局:美国全国性研究。
Am J Obstet Gynecol. 2021 Nov;225(5):534.e1-534.e38. doi: 10.1016/j.ajog.2021.04.233. Epub 2021 Apr 21.
8
Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.胎盘植入谱系疾病:产前超声影像学的病理生理学和基于证据的解剖学。
Am J Obstet Gynecol. 2018 Jan;218(1):75-87. doi: 10.1016/j.ajog.2017.05.067. Epub 2017 Jun 24.
9
Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.产前影像学检查提示胎盘植入高风险孕妇的紧急分娩:系统评价和荟萃分析。
Am J Obstet Gynecol MFM. 2024 Oct;6(10):101432. doi: 10.1016/j.ajogmf.2024.101432. Epub 2024 Jul 26.
10
Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.胎盘植入谱系疾病子宫动脉栓塞术和氨甲环酸方案的实施和结果。
Am J Obstet Gynecol. 2023 Jul;229(1):61.e1-61.e7. doi: 10.1016/j.ajog.2023.03.028. Epub 2023 Mar 23.

引用本文的文献

1
Advances in Prenatal Diagnosis of Placenta Accreta Spectrum.胎盘植入谱系疾病的产前诊断进展
Medicina (Kaunas). 2025 Feb 24;61(3):392. doi: 10.3390/medicina61030392.
2
Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine-scar dehiscence.探索病理生理学见解以提高超声标志物在鉴别胎盘植入谱系疾病与子宫瘢痕裂开方面的诊断效用。
Ultrasound Obstet Gynecol. 2025 Jan;65(1):85-93. doi: 10.1002/uog.29144. Epub 2024 Dec 15.
3
Prenatal detection of placenta accreta spectrum using a sonographic checklist.
使用超声检查清单进行胎盘植入谱系疾病的产前检测。
Acta Obstet Gynecol Scand. 2025 Apr;104 Suppl 1(Suppl 1):56-65. doi: 10.1111/aogs.14943. Epub 2024 Oct 2.
4
Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases.经腹和经阴道超声检查结果有助于指导胎盘植入谱系病例的临床管理。
Acta Obstet Gynecol Scand. 2024 Jan;103(1):93-102. doi: 10.1111/aogs.14715. Epub 2023 Nov 15.
5
Placenta Accreta Spectrum.胎盘植入谱系疾病
Obstet Gynecol. 2023 Jul 1;142(1):31-50. doi: 10.1097/AOG.0000000000005229. Epub 2023 Jun 7.
6
The prenatal diagnostic indicators of placenta accreta spectrum disorders.胎盘植入谱系疾病的产前诊断指标。
Heliyon. 2023 May 17;9(5):e16241. doi: 10.1016/j.heliyon.2023.e16241. eCollection 2023 May.
7
Placental and Umbilical Cord Anomalies Diagnosed by Two- and Three-Dimensional Ultrasound.二维和三维超声诊断胎盘及脐带异常
Diagnostics (Basel). 2022 Nov 16;12(11):2810. doi: 10.3390/diagnostics12112810.
8
Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis.胎盘植入谱系障碍合并子宫内膜异位症:系统评价与Meta分析
Biomedicines. 2022 Feb 6;10(2):390. doi: 10.3390/biomedicines10020390.
9
Ultrasound as a Sole Modality for Prenatal Diagnosis of Placenta Accreta Spectrum: Potentialities and Pitfalls.超声作为胎盘植入谱系产前诊断的单一方式:潜力与局限
Indian J Radiol Imaging. 2021 Oct 19;31(3):527-538. doi: 10.1055/s-0041-1735864. eCollection 2021 Jul.